About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
Track Our News on
All
Press Release
Media Coverage
All
2023-10-20
2023-10-18
2023-10-11
2023-09-07
2023-09-01
2023-08-10
2023-07-29
2023-07-18
2023-06-12
2023-04-05
2023-01-17
2023-01-12
Previous
3 / 5
Next
Previous
3 / 5
Next
MindRank Awarded “Future Unicorn | The Inaugural Dual 30 AI Ranking of Innovative Companies” by KPMG China
Journal of Biomolecular Structure and Dynamics | The Binding Mechanism of Failed, in Processing and Succeed Inhibitors Target SARS-CoV-2 Main Protease
Bioinformatics | An Extensive Benchmark Study on Biomedical Text Generation and Mining with ChatGPT
MindRank Announces the Commencement of Phase IIa Clinical Study of MDR-001 in China
MindRank Features in Forbes Asia 100 to Watch 2023 List
MindRank Secures Funding from the Dynamic Resilience Program for its Pan-European Collaborative Project
ICML 2023 | Rethinking Explaining Graph Neural Networks via Non-parametric Subgraph Matching
MindRank Secures Over $20 Million in A+ Round Financing, Propelling Innovative Drug Pipeline and AI Platform Commercialization
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
Commun. Chem. (Nature) | Pharmacophoric-Constrained Heterogeneous Graph Transformer Model for Molecular Property Prediction
News - MindRank
MindRank Made the List of 2022 China's Top 10 Most Potential ScienceAI Startups by Synced
MindRank was Nominated for the 2022 Venture50 List by Zero2IPO Group and Pedaily
